期刊首页 优先出版 当期阅读 过刊浏览 作者中心 关于期刊 English

2010年 第4卷 第4期

摘要

关键词

相关研究

回顶部

《医学前沿（英文）》 >> 2010年 第4卷 第4期 doi: 10.1007/s11684-010-0230-3

The value of epigenetic markers in esophageal cancer

Department of Gastroenterology & Hepatology, Chinese PLA General Hospital, Beijing 100853, China;

发布日期： 2010-12-05
HTML20 PDF 3 收藏 0

下一篇 上一篇

摘要

Developing esophageal cancer is a multi-step process that begins with the accumulation of genetic and epigenetic alterations, and leads to the activation of oncogenes and the inactivation or loss of tumor suppressor genes (TSG). In addition to genetic alteration, epigenetic modifications, and in particular DNA methylation, are recognized as a common molecular alteration in human tumors. In esophageal cancer, aberrant methylation of promoter regions occurs not only in advanced cancer, but also in premalignant lesions. DNA methylation is related to survival time and sensitivity of chemoradiotherapy. This review is mainly focused on epigenetic changes in esophageal cancer and the value of early detection for patient prognosis, treatment choices, and potential targeting therapy.

相关研究